Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0822 placebo-controlled phase IIa trial in knee osteoarthritis
2006-005956-34Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in osteoarthritis (OA) comparing MK-0822 5 mg once daily with Placebo once daily (2 arms). Started Jan 2007; status: completed.
02
Drugs
odanacatib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2006-005956-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005956-34.